Testing the Addition of the Anti-cancer Viral Therapy Telomelysinâ„¢ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
NRG Oncology
NRG Oncology
National Institutes of Health Clinical Center (CC)
Rigshospitalet, Denmark